Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.03 EUR
Change Today -0.001 / -3.45%
Volume 0.0
LHI On Other Exchanges
As of 2:08 AM 11/30/15 All times are local (Market data is delayed by at least 15 minutes).

living cell technologies ltd (LHI) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/26/15 - €0.04
52 Week Low
08/24/15 - €0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

living cell technologies ltd (LHI) Related Businessweek News

No Related Businessweek News Found

living cell technologies ltd (LHI) Details

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore function worldwide. The company’s therapeutic candidates include DIABECELL, which is in late-stage clinical trials for the treatment of type 1 diabetes; and NTCELL, which is in Phase I/IIa clinical trials for the treatment of Parkinson’s disease. It has a collaboration agreement with the Centre for Brain Research to identify neurodegenerative disease targets for clinical studies of NTCELL product. The company was founded in 1987 and is based in Auckland, New Zealand.

Founded in 1987

living cell technologies ltd (LHI) Top Compensated Officers

Chief Executive
Total Annual Compensation: A$317.0K
Co-Founder and Non-Executive Director
Total Annual Compensation: A$128.0K
Head of Finance & Administration
Total Annual Compensation: A$192.9K
Compensation as of Fiscal Year 2015.

living cell technologies ltd (LHI) Key Developments

Living Cell Technologies Limited Announces Cash Flow Results for the First Quarter Ended September 30, 2015

Living Cell Technologies Limited announced cash flow results for the first quarter ended September 30, 2015. For the quarter, the company reported net operating cash flow was $695,917 compared to $1,320,618 in the previous quarter.

Living Cell Technologies Limited Reports Earnings Results for the Year Ended June 30, 2015

Living Cell Technologies Limited reported earnings results for the year ended June 30, 2015. The company net loss for the financial year to 30 June 2015 was $7,043,402 compared to a loss of $6,778,896 in the prior year. The increased loss was due to the increased clinical trial activity and the absence of recovery of clinical trial expenses fee from Otsuka Pharmaceutical Factory Inc. as a result of termination of the co-development agreement in May 2014.

Living Cell Technologies Limited, Annual General Meeting, Nov 10, 2015

Living Cell Technologies Limited, Annual General Meeting, Nov 10, 2015., at 14:00 NZST - New Zealand Standard. Location: Pullman Auckland, Cnr. Princes Street and Waterloo Quadrant.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LHI:GR €0.03 EUR -0.001

LHI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LHI.
View Industry Companies

Industry Analysis


Industry Average

Valuation LHI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 20.7x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.3x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LIVING CELL TECHNOLOGIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at